Telesis Bio, Inc.
TBIO
$0.30
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -61.79% | -77.87% | -53.21% | -26.32% | -38.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -61.79% | -77.87% | -53.21% | -26.32% | -38.61% |
| Cost of Revenue | -64.34% | 15.20% | -42.90% | -26.30% | -48.21% |
| Gross Profit | -60.21% | -116.09% | -60.22% | -26.33% | -30.69% |
| SG&A Expenses | -53.65% | -15.10% | -25.53% | -25.76% | -9.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -50.21% | -16.77% | -34.21% | -24.69% | -24.82% |
| Operating Income | 45.15% | -40.74% | 25.74% | 22.73% | 16.64% |
| Income Before Tax | 37.51% | -48.99% | 25.62% | -117.62% | 19.64% |
| Income Tax Expenses | -92.86% | -75.00% | -33.33% | -50.00% | 133.33% |
| Earnings from Continuing Operations | 37.59% | -48.92% | 25.62% | -117.50% | 19.56% |
| Earnings from Discontinued Operations | 36.64% | -95.42% | -50.21% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 37.52% | -51.86% | 22.32% | -117.50% | 13.67% |
| EBIT | 45.15% | -40.74% | 25.74% | 22.73% | 16.64% |
| EBITDA | 47.30% | -40.02% | 28.21% | 26.22% | 17.81% |
| EPS Basic | 39.18% | -49.31% | 18.20% | -121.28% | 10.35% |
| Normalized Basic EPS | 49.17% | -29.90% | 27.85% | 25.32% | 15.81% |
| EPS Diluted | 39.18% | -49.31% | 18.20% | -121.28% | 10.35% |
| Normalized Diluted EPS | 49.17% | -29.90% | 27.85% | 25.32% | 15.81% |
| Average Basic Shares Outstanding | 6.55% | 4.60% | 1.40% | 1.50% | 1.45% |
| Average Diluted Shares Outstanding | 6.55% | 4.60% | 1.40% | 1.50% | 1.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
